MHRA - Regulator’s experience of clinical trials during the Covid-19 pandemic (Part 2) – what we have learned

15th February 2022

MHRA - Regulator’s experience of clinical trials during the Covid-19 pandemic (Part 2) – what we have learned.

In part one of this series, MHRA explored as an introduction how we initially responded to the Covid-19 pandemic to move faster in the set-up and approval of clinical trials. Now they look at the unprecedented challenges we faced in each area and the lessons we have learned during the last two years.

Read More

Back to News Archive